Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma

World Journal of Surgery

Volumn 27, Issue 9, 2003, Pages 994-998

  Clark, Geoffrey W B ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CAGA PROTEIN;

ADENOCARCINOMA; ADULT; ARTICLE; BACTERIAL INFECTION; BARRETT ESOPHAGUS; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; ESOPHAGUS TUMOR; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RATE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTICENTER STUDY; NONHUMAN; PREVALENCE; REFLUX ESOPHAGITIS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0141765770     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7051-3     Document Type: Article

References (52)

1. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;330:1273-1275
2. Buckley MJM, O'Shea J, Grace A, et al. A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology. Eur. J. Gastroenterol. Hepatol. 1998;10:375-379
3. Whitaker CJ, Dubiel AJ, Galpin OP. Social and geographic risk factors in Helicobacter pylori. Epidemiol. Infect. 1993;111:63-70
4. Bowrey DJ, Williams GT, Clark GWB. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Dis. Esophagus 1998;11:203-209
5. Bowrey DJ, Clark GWB, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999;45:798-803
6. O'Connor HE, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease: a prospective study. Ir. J. Med. Sci. 1994;163:369-373
7. Befrits R, Granstrom M, Rylander M, et al. Helicobacter pylori in 205 consecutive endoscopy patients. Scand. J. Infect. Dis. 1993;25:185-191
8. Newton M, Bryan R, Burnham WR, et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997;40:9-13
9. Werdmuller BF, Loffield RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig. Dis. Sci. 1997;42:103-105
10. Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 controls and 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis. Esophagus 1997;10:38-42
11. El-Omar EM, Penman ID, Ardill JES, et al. Helicobacter pylori infection and acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-691
12. Tham TC, Chen L, Dennison N, et al. Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur. J. Gastroenterol. Hepatol. 1998;10:289-291
13. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterol. 1997;113:15-24
14. Schutze K, Hentschel E, Dragosics B, et al. Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses. Gut 1995;36:831-833
15. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology 1997;112:1442-1447
16. Talley NJ, Janssens J, Lauritsen K, et al. No increase in reflux symptoms or esophagitis in patients treated with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication: a randomised double-blind placebo-controlled trial. Gastroenterology 1998;114:A306
17. Verdu EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-543
18. Holtmann G, Cain CR, Malferttheiner P. The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole. Gastroenterology 1998;114:A151
19. Lambert R, Creutzfeldt W, Struber HG, et al. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth and gastritis. Gastroenterology 1993;104:1356-1370
20. Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis: a contolled double blind trial of their efficiency and safety. Gut 1995;35:590-598
21. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long-term treatment with omeprazole for refractory reflux oesophagitis: efficacy and safety. Ann. Intern. Med. 1994;121:161-167
22. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppression therapy: implications for long-term safety. Am. J. Gastroenterol. 1995;36:539-543
23. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med. 1996;334:1018-1022
24. Schenk BE, Kuipers EJ, Nelis GF, et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 2000;46:615-621
25. Clark GWB, Ireland AP, Peters JH, et al. Short segment Barrett's oesophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J. Gastrointestinal. Surg. 1997;1:113-122
26. Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-754
27. Henihan RDJ, Staurt RC, Nolan N, et al. Barrett's esophagus and the presence of Helicobacter pylori. Am. J. Gastroenterol. 1998;93:542-546
28. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988;95:216-218
29. Ricaurte O, Flejou JF, Vissuzaine C, et al. Helicobacter pylori infection in patients with Barrett's esophagus: a prospective immunohistochemical study. J. Clin. Pathol. 1996;49:176-177
30. Weston AP, Cherian R, Horvat R, et al. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma and Helicobacter pylori. Am. J. Gastroenterol. 1997;92:800-804
31. Blaser MJ, Perez-Perez GI, Lindenbaum J, et al. Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology. Rev. Infect. Dis. 1991;13:704-708
32. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-57
33. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am. J. Gastroenterol. 1992;87:1598-1600
34. Wright TA, Kingsnorth AN. High incidence of Helicobacter pylori colonisation of Barrett's oesophagus. Gut 1995;36:A38
35. Peters FTM, Kuipers EJ, Ganesh S, et al. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy. Aliment. Pharmacol. Ther. 1999;13:921-926
36. Clark GWB, Ireland AP, Chandrasoma P, et al. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: a new marker for gastroesophageal reflux disease. Gastroenterology 1994;106:A63
37. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-1536
38. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am. J. Gastroenterol. 1996;91:1507-1511
39. Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig. Dis. Sci. 1997;42:603-607
40. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am. J. Gastroenterol. 1997;92:414-418
41. Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-715
42. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann. Surg. 1997;226:522-532
43. Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-589
44. Dias Pereira A, Suspiro A, Chaves P, et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities. Gut 1998;42:659-662
45. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux disease and H. pylori infection. Gastroenterology 1998;114:633-639
46. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastrooesophageal reflux disease. Gut 1998;43:17-21
47. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy. Am. J. Surg. Pathol. 1996;20 (Suppl 1):S31-50
48. Voutilainen M, Fakkila M, Juhola M, et al. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagits and gastritis. Gut 1999;45:644-648
49. Quddus MR, Henley JD, Sulaiman RA, et al. Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Hum. Pathol. 1997;28:1007-1009
50. Wright TA, Myskow M, Kingsnorth AN. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis. Esophagus 1997;10:196-200
51. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric adenocarcinoma. Cancer Res. 1988;58:588-590
52. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999;340:825-831